在三阴性乳腺癌细胞中MALAT1的下调
Dagmara Klopotowska1, Janusz Matuszyk1
1Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.
Biochemistry and biophysics reports
|December 13, 2023
概括
长非编码RNA MALAT1 在侵袭性三阴性乳腺癌细胞系中被下调. 这项研究澄清了MALAT1.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 长非编码RNAMALAT1在细胞核中丰富,在各种癌症中升高.
- 关于乳腺癌细胞系中MALAT1的相互矛盾的报告需要进一步调查.
- 了解MALAT1的作用对于乳腺癌进展研究至关重要.
研究的目的:
- 在三阴性乳腺癌 (TNBC) 和光线性乳腺癌细胞系中量化MALAT1转录水平.
- 确定不同乳腺癌亚型中MALAT1的表达模式.
- 澄清MALAT1在乳腺癌进展中的作用.
主要方法:
- 使用定量实时PCR (qPCR) 来测量MALAT1转录的正常化相对量 (NRQ).
- 总RNA被从光线 (T47D,MCF-7),TNBC (MDA-MB-468,CAL-51,MDA-MB-231) 和正常 (MCF-10A) 乳腺细胞系中分离出来.
- 鉴定出CCSER2是MALAT1正常化的一个可靠的参考基因.
主要成果:
- 对于MALAT1 NRQ,CCSER2规范化提供了最窄的置信区间.
- 与正常和光细胞相比,TNBC细胞系中的MALAT1主要转录水平显著降低.
- 在大多数乳腺癌细胞系中,MALAT1少数拼接变体的增加.
结论:
- CCSER2规范化的qPCR数据表明,在侵袭性乳腺癌亚型中,MALAT1的下调.
- 与正常和雌激素受体阳性乳腺癌细胞系相比,在TNBC中观察到这种下调.
- 研究结果表明,MALAT1结合变异在乳腺癌中起着复杂的作用.
相关概念视频
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K


